BioStrand Omics Analysis Blog:
Multi-Omics

Multidimensional scalability in multi-omics research

In 2018, the Joint Genome Institute (JGI) achieved a sequencing output of 200 trillion bases, a...

Multi-omics data in biomarker discovery

Current diagnostic alternatives for neurodegenerative diseases like Alzheimer’s, Parkinson’s,...

Build vs. Buy: 7 Pros and Cons to Consider

There are multiple challenges associated with an increasing amount of data of which a key...

Convenience, Scalability, and Integration, in Three Flavours of BioStrand R&R

Omics data related to the genome, proteome and transcriptome is the very lifeblood of Life...

Making all omics data computable

At the beginning of the last decade, the Harvard Business Review described data science as the ...

Finish Your PhD Faster with BioStrand R&R

It has been two decades since the publication of the much-heralded first draft of a composite...

Harnessing the power of sequence information to enable the next breakthroughs in biology

The availability of high-quality genomes, transcriptome and protein assemblies are crucial for...

Disrupting Multi-Omics Data Analysis: 5 Key Highlights of BioStrand

There are currently several programs underway across the globe, such as the 1+ Million Genomes...

Multi-domain analysis: why having multi-omics layers under a single hood matters?

Sequencing and spectrometry techniques are advancing at a rapid pace, providing more and more...